Nonbenzamidine compounds as selective factor Xa inhibitors

被引:17
作者
He, W
Hanney, B
Myers, MR
Spada, AP
Brown, K
Colussi, D
Chu, V
机构
[1] Aventis Pharmaceut, Dept Med Chem, SW 8, Collegeville, PA 19426 USA
[2] Aventis Pharmaceut, Dept Cardiovasc Biol, SW4, Collegeville, PA 19426 USA
关键词
D O I
10.1016/S0960-894X(00)00316-4
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
Nonbenzamidine compounds (imidazole, pyridine, pyrimidine, and thiazole derivatives) as selective serine protease factor Xa inhibitors are discussed. (C) 2000 Elsevier Science Ltd. All rights reserved.
引用
收藏
页码:1737 / 1739
页数:3
相关论文
共 12 条
[1]   Factor Xa inhibitors [J].
Al-Obeidi, F ;
Ostrem, JA .
EXPERT OPINION ON THERAPEUTIC PATENTS, 1999, 9 (07) :931-953
[2]  
CHU V, 2000, IN PRESS THROMB RES
[3]  
Ewing William R., 1999, Drugs of the Future, V24, P771, DOI 10.1358/dof.1999.024.07.858624
[4]  
EWING WR, 1999, Patent No. 37304
[5]  
EWING WR, 2000, 219 NAT M AM CHEM SO
[6]  
Fevig JM, 1999, ANNU REP MED CHEM, V34, P81
[7]   Synthetic inhibitors of thrombin and factor Xa:: From bench to bedside [J].
Hauptmann, J ;
Stürzebecher, J .
THROMBOSIS RESEARCH, 1999, 93 (05) :203-241
[8]  
ISAACS RCA, 1999, 217 NAT M AM CHEM SO
[9]   FACTOR XA INHIBITORS AS NOVEL ANTITHROMBOTIC AGENTS - FACTS AND PERSPECTIVES [J].
KAISER, B ;
HAUPTMANN, J .
CARDIOVASCULAR DRUG REVIEWS, 1994, 12 (03) :225-236
[10]   Coagulation factor Xa: The prothrombinase complex as an emerging therapeutic target for small molecule inhibitors [J].
Scarborough, RM .
JOURNAL OF ENZYME INHIBITION, 1998, 14 (01) :15-25